COLL | Collegium PharmaceuticalNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$23.68
-$0.12 (-0.50%)

Collegium Pharmaceutical (COLL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is below both. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
between the two $23.68 vs 50 $23.23 / 200 $33.12
Projection
No cross projected
Test
No active test
Last cross
Death cross 14 Apr 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $23.80 vs 50 $35.52 / 200 $31.62
Projection
Death cross projected in 10 bars
Test
No active test
Last cross
Golden cross week of 9 Jan 2023 ยท projected 20 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $23.89 vs 50 $22.72 / 200 $28.40
Projection
No cross projected
Test
No active test
Last cross
Death cross 12 Aug 2026 ยท projected 14 bars out

Cross history

25
crosses on record since 2017
12 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
12 Aug 2026Death4-hour14 bars outNot tested
16 Jul 2026Golden4-hour26 bars out4 bar cross test
14 Apr 2026Death steepdaily30 bars outNot tested
10 Mar 2026Death4-hour23 bars outNot tested
4 Aug 2025Golden moderatedaily25 bars out2 bar cross test

About COLL

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$19.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.